| Literature DB >> 30552022 |
Yuki Nakanishi1, Angeles Duran1, Antoine L'Hermitte1, Phillip M Shelton1, Naoko Nakanishi1, Miguel Reina-Campos2, Jianfeng Huang1, Ferran Soldevila3, Bas J G Baaten3, Daniele V F Tauriello4, Elias A Castilla1, Munveer S Bhangoo5, Fei Bao6, Darren Sigal5, Maria T Diaz-Meco1, Jorge Moscat7.
Abstract
Serrated adenocarcinoma, an alternative pathway for colorectal cancer (CRC) development, accounts for 15%-30% of all CRCs and is aggressive and treatment resistant. We show that the expression of atypical protein kinase C ζ (PKCζ) and PKCλ/ι was reduced in human serrated tumors. Simultaneous inactivation of the encoding genes in the mouse intestinal epithelium resulted in spontaneous serrated tumorigenesis that progressed to advanced cancer with a strongly reactive and immunosuppressive stroma. Whereas epithelial PKCλ/ι deficiency led to immunogenic cell death and the infiltration of CD8+ T cells, which repressed tumor initiation, PKCζ loss impaired interferon and CD8+ T cell responses, which resulted in tumorigenesis. Combined treatment with a TGF-β receptor inhibitor plus anti-PD-L1 checkpoint blockade showed synergistic curative activity. Analysis of human samples supported the relevance of these kinases in the immunosurveillance defects of human serrated CRC. These findings provide insight into avenues for the detection and treatment of this poor-prognosis subtype of CRC.Entities:
Keywords: PKCζ; PKCλ/ι; TGF-β; atypical PKCs; colorectal cancer; immunosuppression; immunosurveillance; interferon; intestinal inflammation; serrated adenocarcinoma
Mesh:
Substances:
Year: 2018 PMID: 30552022 PMCID: PMC6301096 DOI: 10.1016/j.immuni.2018.09.013
Source DB: PubMed Journal: Immunity ISSN: 1074-7613 Impact factor: 31.745